ClinicalMetric / Countries / Australia / obesity
← 🇦🇺 Australia Trials
🇦🇺 Australia Country × Condition

obesity Clinical Trials in Australia

Active clinical trials for obesity with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 3, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇺 Australia

Active Trials in Australia (3)

NCT07684235 Phase 3
Recruiting

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Enrollment
3,200 pts
Country
🇦🇺 Australia
Amgen
View Trial →
NCT07098663 Phase 2
Recruiting

Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes

Enrollment
68 pts
Country
🇦🇺 Australia
Mankind Pharma Limited
View Trial →
NCT07481630 Phase 3
Recruiting

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Enrollment
400 pts
Country
🇦🇺 Australia
Novo Nordisk A/S
View Trial →

Frequently Asked Questions

How many obesity clinical trials are active in Australia?
There are currently 3 active clinical trials for obesity with sites in Australia, of which 3 are actively recruiting patients.
How can I join a obesity clinical trial in Australia?
To join a obesity clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are obesity trials in Australia?
Active obesity trials in Australia span Phase 3, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Australia Trials → Global obesity Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology